- Home
- All Stock List
- NSE
- Syngene International Ltd Share Price
627.95
-6.10 (-0.96%)
-
Underperforms Index
-8.63%
Return (1Y)
Underperformed Nifty 500 by 13%
-
More Volatile
1.88%
Standard Deviation (1Y)
Higher than Nifty 500 by 0.83%
-
Consistent Performer
7/12
Months
beaten Nifty 500
-
AxisDirect View
No View
961
608
News & Announcements
-
On a consolidated basis, net profit of Syngene International declined 2.81% to Rs 183.30 crore while net sales rose 11.03% to Rs 1018 crore in Q4 March 2025 over Q4 March 2024. Reported EBITDA rose 9% year-on-year to Rs 363 crore in Q4 March 2025. EBITDA margin (%) stood at 35% in Q4FY25, lower than 35.7% in Q4FY24.
For the full year, net profit declined 2.71% to Rs 496.20 crore while net sales rose 4.41% to Rs 3642.40 crore in the year ended March 2025 over the year ended March 2024. Reported EBITDA rose 1% year-on-year to Rs 1,114 crore in FY25. EBITDA margin (%) stood at 30% in FY25, lower than 30.9% in FY24.
In its outlook for FY26, the Syngene management anticipates the reported revenue growth will likely be in the mid-single digits. They also foresee the EBITDA margin moderating from current levels to the mid-twenties and a year-on-year decline in profit after tax.
Commenting on the results, Peter Bains, managing director and CEO, Syngene International, said, Looking at the year ahead, while the wider global market dynamics remain uncertain, we expect the business momentum to continue with pipeline build in both small and large molecules, supported by new pilot programs and conversion of existing pilots in discovery services. On an underlying basis for fiscal year 2026, we expect revenue growth in the early teens reflecting a broad-based growth across research, development and manufacturing services. Adjusted for inventory balancing in large molecule commercial manufacturing at client level, the reported revenue growth is likely to be at mid-single digit.
Deepak Jain, chief financial officer, Syngene International, said, Looking ahead into the next financial year, we expect the momentum to continue, with reported revenue growth at the mid-single digit level. As we bring the new biologics manufacturing facilities into operations, the additional operating costs and depreciation will impact margins. With this, we expect EBITDA margin to moderate from current levels to the mid-twenties and year-on-year decline in profit after tax.
The company's board recommended a final dividend of Re 1.25 per equity share for the financial year 2024-25.
Syngene International is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.
Powered by Capital Market - Live News
-
Nava Ltd, 360 ONE WAM Ltd, KFin Technologies Ltd and Can Fin Homes Ltd are among the other losers in the BSE's 'A' group today, 24 April 2025.
Syngene International Ltd lost 13.07% to Rs 652 at 14:47 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 6.27 lakh shares were traded on the counter so far as against the average daily volumes of 16486 shares in the past one month.
Nava Ltd tumbled 4.70% to Rs 470.05. The stock was the second biggest loser in 'A' group.On the BSE, 37641 shares were traded on the counter so far as against the average daily volumes of 34596 shares in the past one month.
360 ONE WAM Ltd crashed 4.30% to Rs 1015.75. The stock was the third biggest loser in 'A' group.On the BSE, 62266 shares were traded on the counter so far as against the average daily volumes of 68845 shares in the past one month.
KFin Technologies Ltd fell 4.26% to Rs 1231.55. The stock was the fourth biggest loser in 'A' group.On the BSE, 73027 shares were traded on the counter so far as against the average daily volumes of 1.36 lakh shares in the past one month.
Can Fin Homes Ltd plummeted 4.26% to Rs 713. The stock was the fifth biggest loser in 'A' group.On the BSE, 39072 shares were traded on the counter so far as against the average daily volumes of 20594 shares in the past one month.
Powered by Capital Market - Live News
-
Natco Pharma Ltd, Newgen Software Technologies Ltd, MMTC Ltd, Glaxosmithkline Pharmaceuticals Ltd are among the other stocks to see a surge in volumes on NSE today, 24 April 2025.
Syngene International Ltd registered volume of 168.31 lakh shares by 14:14 IST on NSE, a 34.31 fold spurt over two-week average daily volume of 4.91 lakh shares. The stock slipped 12.51% to Rs.655.45. Volumes stood at 6.35 lakh shares in the last session.
Natco Pharma Ltd clocked volume of 144.27 lakh shares by 14:14 IST on NSE, a 34.05 times surge over two-week average daily volume of 4.24 lakh shares. The stock gained 8.94% to Rs.920.00. Volumes stood at 3.69 lakh shares in the last session.
Newgen Software Technologies Ltd saw volume of 117.97 lakh shares by 14:14 IST on NSE, a 28.87 fold spurt over two-week average daily volume of 4.09 lakh shares. The stock increased 13.03% to Rs.1,122.60. Volumes stood at 14 lakh shares in the last session.
MMTC Ltd registered volume of 410.32 lakh shares by 14:14 IST on NSE, a 26.01 fold spurt over two-week average daily volume of 15.78 lakh shares. The stock rose 14.15% to Rs.63.73. Volumes stood at 14.89 lakh shares in the last session.
Glaxosmithkline Pharmaceuticals Ltd recorded volume of 17.98 lakh shares by 14:14 IST on NSE, a 14.9 times surge over two-week average daily volume of 1.21 lakh shares. The stock gained 3.19% to Rs.2,937.50. Volumes stood at 85241 shares in the last session.
Powered by Capital Market - Live News
-
Nava Ltd, 360 ONE WAM Ltd, KFin Technologies Ltd and Can Fin Homes Ltd are among the other losers in the BSE's 'A' group today, 24 April 2025.
Syngene International Ltd lost 13.07% to Rs 652 at 14:47 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 6.27 lakh shares were traded on the counter so far as against the average daily volumes of 16486 shares in the past one month.
Nava Ltd tumbled 4.70% to Rs 470.05. The stock was the second biggest loser in 'A' group.On the BSE, 37641 shares were traded on the counter so far as against the average daily volumes of 34596 shares in the past one month.
360 ONE WAM Ltd crashed 4.30% to Rs 1015.75. The stock was the third biggest loser in 'A' group.On the BSE, 62266 shares were traded on the counter so far as against the average daily volumes of 68845 shares in the past one month.
KFin Technologies Ltd fell 4.26% to Rs 1231.55. The stock was the fourth biggest loser in 'A' group.On the BSE, 73027 shares were traded on the counter so far as against the average daily volumes of 1.36 lakh shares in the past one month.
Can Fin Homes Ltd plummeted 4.26% to Rs 713. The stock was the fifth biggest loser in 'A' group.On the BSE, 39072 shares were traded on the counter so far as against the average daily volumes of 20594 shares in the past one month.
Powered by Capital Market - Live News
-
Natco Pharma Ltd, Newgen Software Technologies Ltd, MMTC Ltd, Glaxosmithkline Pharmaceuticals Ltd are among the other stocks to see a surge in volumes on NSE today, 24 April 2025.
Syngene International Ltd registered volume of 168.31 lakh shares by 14:14 IST on NSE, a 34.31 fold spurt over two-week average daily volume of 4.91 lakh shares. The stock slipped 12.51% to Rs.655.45. Volumes stood at 6.35 lakh shares in the last session.
Natco Pharma Ltd clocked volume of 144.27 lakh shares by 14:14 IST on NSE, a 34.05 times surge over two-week average daily volume of 4.24 lakh shares. The stock gained 8.94% to Rs.920.00. Volumes stood at 3.69 lakh shares in the last session.
Newgen Software Technologies Ltd saw volume of 117.97 lakh shares by 14:14 IST on NSE, a 28.87 fold spurt over two-week average daily volume of 4.09 lakh shares. The stock increased 13.03% to Rs.1,122.60. Volumes stood at 14 lakh shares in the last session.
MMTC Ltd registered volume of 410.32 lakh shares by 14:14 IST on NSE, a 26.01 fold spurt over two-week average daily volume of 15.78 lakh shares. The stock rose 14.15% to Rs.63.73. Volumes stood at 14.89 lakh shares in the last session.
Glaxosmithkline Pharmaceuticals Ltd recorded volume of 17.98 lakh shares by 14:14 IST on NSE, a 14.9 times surge over two-week average daily volume of 1.21 lakh shares. The stock gained 3.19% to Rs.2,937.50. Volumes stood at 85241 shares in the last session.
Powered by Capital Market - Live News
-
Syngene International to conduct AGM
9 days ago
-
On a consolidated basis, net profit of Syngene International declined 2.81% to Rs 183.30 crore while net sales rose 11.03% to Rs 1018 crore in Q4 March 2025 over Q4 March 2024. Reported EBITDA rose 9% year-on-year to Rs 363 crore in Q4 March 2025. EBITDA margin (%) stood at 35% in Q4FY25, lower than 35.7% in Q4FY24.
For the full year, net profit declined 2.71% to Rs 496.20 crore while net sales rose 4.41% to Rs 3642.40 crore in the year ended March 2025 over the year ended March 2024. Reported EBITDA rose 1% year-on-year to Rs 1,114 crore in FY25. EBITDA margin (%) stood at 30% in FY25, lower than 30.9% in FY24.
In its outlook for FY26, the Syngene management anticipates the reported revenue growth will likely be in the mid-single digits. They also foresee the EBITDA margin moderating from current levels to the mid-twenties and a year-on-year decline in profit after tax.
Commenting on the results, Peter Bains, managing director and CEO, Syngene International, said, Looking at the year ahead, while the wider global market dynamics remain uncertain, we expect the business momentum to continue with pipeline build in both small and large molecules, supported by new pilot programs and conversion of existing pilots in discovery services. On an underlying basis for fiscal year 2026, we expect revenue growth in the early teens reflecting a broad-based growth across research, development and manufacturing services. Adjusted for inventory balancing in large molecule commercial manufacturing at client level, the reported revenue growth is likely to be at mid-single digit.
Deepak Jain, chief financial officer, Syngene International, said, Looking ahead into the next financial year, we expect the momentum to continue, with reported revenue growth at the mid-single digit level. As we bring the new biologics manufacturing facilities into operations, the additional operating costs and depreciation will impact margins. With this, we expect EBITDA margin to moderate from current levels to the mid-twenties and year-on-year decline in profit after tax.
The company's board recommended a final dividend of Re 1.25 per equity share for the financial year 2024-25.
Syngene International is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.
Powered by Capital Market - Live News
-
Nava Ltd, 360 ONE WAM Ltd, KFin Technologies Ltd and Can Fin Homes Ltd are among the other losers in the BSE's 'A' group today, 24 April 2025.
Syngene International Ltd lost 13.07% to Rs 652 at 14:47 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 6.27 lakh shares were traded on the counter so far as against the average daily volumes of 16486 shares in the past one month.
Nava Ltd tumbled 4.70% to Rs 470.05. The stock was the second biggest loser in 'A' group.On the BSE, 37641 shares were traded on the counter so far as against the average daily volumes of 34596 shares in the past one month.
360 ONE WAM Ltd crashed 4.30% to Rs 1015.75. The stock was the third biggest loser in 'A' group.On the BSE, 62266 shares were traded on the counter so far as against the average daily volumes of 68845 shares in the past one month.
KFin Technologies Ltd fell 4.26% to Rs 1231.55. The stock was the fourth biggest loser in 'A' group.On the BSE, 73027 shares were traded on the counter so far as against the average daily volumes of 1.36 lakh shares in the past one month.
Can Fin Homes Ltd plummeted 4.26% to Rs 713. The stock was the fifth biggest loser in 'A' group.On the BSE, 39072 shares were traded on the counter so far as against the average daily volumes of 20594 shares in the past one month.
Powered by Capital Market - Live News
-
Natco Pharma Ltd, Newgen Software Technologies Ltd, MMTC Ltd, Glaxosmithkline Pharmaceuticals Ltd are among the other stocks to see a surge in volumes on NSE today, 24 April 2025.
Syngene International Ltd registered volume of 168.31 lakh shares by 14:14 IST on NSE, a 34.31 fold spurt over two-week average daily volume of 4.91 lakh shares. The stock slipped 12.51% to Rs.655.45. Volumes stood at 6.35 lakh shares in the last session.
Natco Pharma Ltd clocked volume of 144.27 lakh shares by 14:14 IST on NSE, a 34.05 times surge over two-week average daily volume of 4.24 lakh shares. The stock gained 8.94% to Rs.920.00. Volumes stood at 3.69 lakh shares in the last session.
Newgen Software Technologies Ltd saw volume of 117.97 lakh shares by 14:14 IST on NSE, a 28.87 fold spurt over two-week average daily volume of 4.09 lakh shares. The stock increased 13.03% to Rs.1,122.60. Volumes stood at 14 lakh shares in the last session.
MMTC Ltd registered volume of 410.32 lakh shares by 14:14 IST on NSE, a 26.01 fold spurt over two-week average daily volume of 15.78 lakh shares. The stock rose 14.15% to Rs.63.73. Volumes stood at 14.89 lakh shares in the last session.
Glaxosmithkline Pharmaceuticals Ltd recorded volume of 17.98 lakh shares by 14:14 IST on NSE, a 14.9 times surge over two-week average daily volume of 1.21 lakh shares. The stock gained 3.19% to Rs.2,937.50. Volumes stood at 85241 shares in the last session.
Powered by Capital Market - Live News
-
Syngene International to conduct AGM
9 days ago
-
On a consolidated basis, net profit of Syngene International declined 2.81% to Rs 183.30 crore while net sales rose 11.03% to Rs 1018 crore in Q4 March 2025 over Q4 March 2024. Reported EBITDA rose 9% year-on-year to Rs 363 crore in Q4 March 2025. EBITDA margin (%) stood at 35% in Q4FY25, lower than 35.7% in Q4FY24.
For the full year, net profit declined 2.71% to Rs 496.20 crore while net sales rose 4.41% to Rs 3642.40 crore in the year ended March 2025 over the year ended March 2024. Reported EBITDA rose 1% year-on-year to Rs 1,114 crore in FY25. EBITDA margin (%) stood at 30% in FY25, lower than 30.9% in FY24.
In its outlook for FY26, the Syngene management anticipates the reported revenue growth will likely be in the mid-single digits. They also foresee the EBITDA margin moderating from current levels to the mid-twenties and a year-on-year decline in profit after tax.
Commenting on the results, Peter Bains, managing director and CEO, Syngene International, said, Looking at the year ahead, while the wider global market dynamics remain uncertain, we expect the business momentum to continue with pipeline build in both small and large molecules, supported by new pilot programs and conversion of existing pilots in discovery services. On an underlying basis for fiscal year 2026, we expect revenue growth in the early teens reflecting a broad-based growth across research, development and manufacturing services. Adjusted for inventory balancing in large molecule commercial manufacturing at client level, the reported revenue growth is likely to be at mid-single digit.
Deepak Jain, chief financial officer, Syngene International, said, Looking ahead into the next financial year, we expect the momentum to continue, with reported revenue growth at the mid-single digit level. As we bring the new biologics manufacturing facilities into operations, the additional operating costs and depreciation will impact margins. With this, we expect EBITDA margin to moderate from current levels to the mid-twenties and year-on-year decline in profit after tax.
The company's board recommended a final dividend of Re 1.25 per equity share for the financial year 2024-25.
Syngene International is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.
Powered by Capital Market - Live News
-
Nava Ltd, 360 ONE WAM Ltd, KFin Technologies Ltd and Can Fin Homes Ltd are among the other losers in the BSE's 'A' group today, 24 April 2025.
Syngene International Ltd lost 13.07% to Rs 652 at 14:47 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 6.27 lakh shares were traded on the counter so far as against the average daily volumes of 16486 shares in the past one month.
Nava Ltd tumbled 4.70% to Rs 470.05. The stock was the second biggest loser in 'A' group.On the BSE, 37641 shares were traded on the counter so far as against the average daily volumes of 34596 shares in the past one month.
360 ONE WAM Ltd crashed 4.30% to Rs 1015.75. The stock was the third biggest loser in 'A' group.On the BSE, 62266 shares were traded on the counter so far as against the average daily volumes of 68845 shares in the past one month.
KFin Technologies Ltd fell 4.26% to Rs 1231.55. The stock was the fourth biggest loser in 'A' group.On the BSE, 73027 shares were traded on the counter so far as against the average daily volumes of 1.36 lakh shares in the past one month.
Can Fin Homes Ltd plummeted 4.26% to Rs 713. The stock was the fifth biggest loser in 'A' group.On the BSE, 39072 shares were traded on the counter so far as against the average daily volumes of 20594 shares in the past one month.
Powered by Capital Market - Live News
-
Natco Pharma Ltd, Newgen Software Technologies Ltd, MMTC Ltd, Glaxosmithkline Pharmaceuticals Ltd are among the other stocks to see a surge in volumes on NSE today, 24 April 2025.
Syngene International Ltd registered volume of 168.31 lakh shares by 14:14 IST on NSE, a 34.31 fold spurt over two-week average daily volume of 4.91 lakh shares. The stock slipped 12.51% to Rs.655.45. Volumes stood at 6.35 lakh shares in the last session.
Natco Pharma Ltd clocked volume of 144.27 lakh shares by 14:14 IST on NSE, a 34.05 times surge over two-week average daily volume of 4.24 lakh shares. The stock gained 8.94% to Rs.920.00. Volumes stood at 3.69 lakh shares in the last session.
Newgen Software Technologies Ltd saw volume of 117.97 lakh shares by 14:14 IST on NSE, a 28.87 fold spurt over two-week average daily volume of 4.09 lakh shares. The stock increased 13.03% to Rs.1,122.60. Volumes stood at 14 lakh shares in the last session.
MMTC Ltd registered volume of 410.32 lakh shares by 14:14 IST on NSE, a 26.01 fold spurt over two-week average daily volume of 15.78 lakh shares. The stock rose 14.15% to Rs.63.73. Volumes stood at 14.89 lakh shares in the last session.
Glaxosmithkline Pharmaceuticals Ltd recorded volume of 17.98 lakh shares by 14:14 IST on NSE, a 14.9 times surge over two-week average daily volume of 1.21 lakh shares. The stock gained 3.19% to Rs.2,937.50. Volumes stood at 85241 shares in the last session.
Powered by Capital Market - Live News
-
Nava Ltd, 360 ONE WAM Ltd, KFin Technologies Ltd and Can Fin Homes Ltd are among the other losers in the BSE's 'A' group today, 24 April 2025.
Syngene International Ltd lost 13.07% to Rs 652 at 14:47 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 6.27 lakh shares were traded on the counter so far as against the average daily volumes of 16486 shares in the past one month.
Nava Ltd tumbled 4.70% to Rs 470.05. The stock was the second biggest loser in 'A' group.On the BSE, 37641 shares were traded on the counter so far as against the average daily volumes of 34596 shares in the past one month.
360 ONE WAM Ltd crashed 4.30% to Rs 1015.75. The stock was the third biggest loser in 'A' group.On the BSE, 62266 shares were traded on the counter so far as against the average daily volumes of 68845 shares in the past one month.
KFin Technologies Ltd fell 4.26% to Rs 1231.55. The stock was the fourth biggest loser in 'A' group.On the BSE, 73027 shares were traded on the counter so far as against the average daily volumes of 1.36 lakh shares in the past one month.
Can Fin Homes Ltd plummeted 4.26% to Rs 713. The stock was the fifth biggest loser in 'A' group.On the BSE, 39072 shares were traded on the counter so far as against the average daily volumes of 20594 shares in the past one month.
Powered by Capital Market - Live News
-
Natco Pharma Ltd, Newgen Software Technologies Ltd, MMTC Ltd, Glaxosmithkline Pharmaceuticals Ltd are among the other stocks to see a surge in volumes on NSE today, 24 April 2025.
Syngene International Ltd registered volume of 168.31 lakh shares by 14:14 IST on NSE, a 34.31 fold spurt over two-week average daily volume of 4.91 lakh shares. The stock slipped 12.51% to Rs.655.45. Volumes stood at 6.35 lakh shares in the last session.
Natco Pharma Ltd clocked volume of 144.27 lakh shares by 14:14 IST on NSE, a 34.05 times surge over two-week average daily volume of 4.24 lakh shares. The stock gained 8.94% to Rs.920.00. Volumes stood at 3.69 lakh shares in the last session.
Newgen Software Technologies Ltd saw volume of 117.97 lakh shares by 14:14 IST on NSE, a 28.87 fold spurt over two-week average daily volume of 4.09 lakh shares. The stock increased 13.03% to Rs.1,122.60. Volumes stood at 14 lakh shares in the last session.
MMTC Ltd registered volume of 410.32 lakh shares by 14:14 IST on NSE, a 26.01 fold spurt over two-week average daily volume of 15.78 lakh shares. The stock rose 14.15% to Rs.63.73. Volumes stood at 14.89 lakh shares in the last session.
Glaxosmithkline Pharmaceuticals Ltd recorded volume of 17.98 lakh shares by 14:14 IST on NSE, a 14.9 times surge over two-week average daily volume of 1.21 lakh shares. The stock gained 3.19% to Rs.2,937.50. Volumes stood at 85241 shares in the last session.
Powered by Capital Market - Live News
-
Syngene International to conduct AGM
9 days ago
Stock Trivia
Syngene International Ltd is trading very close to its 52 Week Low
FII shareholding in Syngene International Ltd has decreased by -6.95% since past 1 Year
Syngene International Ltd is trading very close to its 52 Week Low
FII shareholding in Syngene International Ltd has decreased by -5.69% since past 3 Months
MF shareholding in Syngene International Ltd has increased by 15.97% since past 3 Months
FII shareholding in Syngene International Ltd has decreased by -6.95% since past 1 Year
Syngene International Ltd is trading very close to its 52 Week Low
FII shareholding in Syngene International Ltd has decreased by -6.95% since past 1 Year
